NCT01453062View on ClinicalTrials.gov

Phase IV Observational Study in Chronic Lymphocytic Leukemia

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Leukaemia, Lymphocytic, Chronic

Interventions

DRUG

Arzerra

Treatment with Arzerra

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01453062 - Phase IV Observational Study in Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter